Dissolved and financials
CVR: 39055988
DKK 1,928,889
Gross profit
Net result: DKK 141,012
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 19 December 2024
CVR · view overview
1 employee
CVR · 2024
Director role ended: Nicolai Jung
CVR · 19/12/2024
View the full event history
EUSA Pharma (Denmark) ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 19 December 2024. The company was registered under the industry Reklamebureauer. The company has 1 employee (2024). In 2023, the company reported a gross profit of DKK 1,928,889 and a net result of DKK 141,012 compared with DKK 198,473 the year before. Equity in the 2023 report amounted to DKK 1,644,740.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202301/01/2023 – 31/12/2023 | 1.9M | 141K | 2M | 1.6M | 1 | |
| 202201/01/2022 – 31/12/2022 | 3M | 198K | 2M | 1.5M | 2 | |
| 202101/01/2021 – 31/12/2021 | 9.4M | 483K | 1.7M | 1.3M | 5 | |
| 202001/01/2020 – 31/12/2020 | 9.8M | 607K | 3M | 823K | 6 | |
| 201901/01/2019 – 31/12/2019 | 2.1M | 228K | 889K | 215K | 3 |
Compared to 1.807 companies in Reklamebureauer
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationNo. EUSA Pharma (Denmark) ApS is registered in the Danish CVR register with the status Dissolved and ceased on 19 December 2024.
The CVR number of EUSA Pharma (Denmark) ApS is 39055988.
In 2023, EUSA Pharma (Denmark) ApS reported a gross profit of DKK 1,928,889.
EUSA Pharma (Denmark) ApS had 1 employee in 2024 according to the Danish CVR register.
EUSA Pharma (Denmark) ApS was founded on 2 November 2017.
EUSA Pharma (Denmark) ApS was registered under the industry Reklamebureauer (industry code 731110).
As of December 19, 2024, CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB has stepped down as auditor of EUSA Pharma (Denmark) ApS.
As of December 19, 2024, Nicolai Jung has stepped down as liquidator of EUSA Pharma (Denmark) ApS.
On December 19, 2024, EUSA Pharma (Denmark) ApS exited liquidation.
EUSA Pharma (Denmark) ApS was dissolved on December 19, 2024.
As of June 3, 2024, Nicolai Jung is registered as liquidator of EUSA Pharma (Denmark) ApS.
As of June 3, 2024, Luigi Longinotti has stepped down as director of EUSA Pharma (Denmark) ApS.
As of June 3, 2024, Francesco Palombi has stepped down as director of EUSA Pharma (Denmark) ApS.
As of June 3, 2024, Joakim Karl Viktor Åberg has stepped down as director of EUSA Pharma (Denmark) ApS.
On June 3, 2024, EUSA Pharma (Denmark) ApS entered liquidation.
EUSA Pharma (Denmark) ApS has published its annual report for 2023. Gross profit came to DKK 1,928,889, and the net result was DKK 141,012.
EUSA Pharma (Denmark) ApS has published its annual report for 2022. Gross profit came to DKK 3,037,780, and the net result was DKK 198,473.
As of October 13, 2022, Francesco Palombi is registered as director of EUSA Pharma (Denmark) ApS.
As of October 13, 2022, Joakim Karl Viktor Åberg is registered as director of EUSA Pharma (Denmark) ApS.
As of October 13, 2022, Dev Kumar has stepped down as director of EUSA Pharma (Denmark) ApS.
As of October 13, 2022, Emma Jane Johnson has stepped down as director of EUSA Pharma (Denmark) ApS.
EUSA Pharma (Denmark) ApS has published its annual report for 2021. Gross profit came to DKK 9,429,497, and the net result was DKK 482,679.
As of March 16, 2022, Luigi Longinotti is registered as director of EUSA Pharma (Denmark) ApS.
As of March 16, 2022, Frank Carsten Thiel has stepped down as director of EUSA Pharma (Denmark) ApS.
EUSA Pharma (Denmark) ApS has published its annual report for 2020. Gross profit came to DKK 9,829,410, and the net result was DKK 607,118.
As of May 25, 2021, Frank Carsten Thiel is registered as director of EUSA Pharma (Denmark) ApS.
As of May 25, 2021, Lee Scot Morley has stepped down as director of EUSA Pharma (Denmark) ApS.
EUSA Pharma (Denmark) ApS has published its annual report for 2019. Gross profit came to DKK 2,058,784, and the net result was DKK 228,408.
EUSA Pharma (Denmark) ApS has published its interim report for the period November 2, 2017 to December 31, 2018.
As of November 2, 2017, CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB has been appointed auditor of EUSA Pharma (Denmark) ApS.
As of November 2, 2017, Dev Kumar is registered as director of EUSA Pharma (Denmark) ApS.
As of November 2, 2017, Emma Jane Johnson is registered as director of EUSA Pharma (Denmark) ApS.
As of November 2, 2017, Lee Scot Morley is registered as director of EUSA Pharma (Denmark) ApS.
EUSA Pharma (Denmark) ApS was founded on November 2, 2017.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 29000255
CVR 46604563
CVR 44208474
CVR 27357474
CVR 21489379
